Literature DB >> 15452455

Suppressive effects of nitric oxide production and inducible nitric oxide synthase (iNOS) gene expression by Calystegia soldanella methanol extract on lipopolysaccharide-activated RAW 264.7 cells.

Y Kim1, H-Y Min, H J Park, E-J Lee, E-J Park, H-J Hwang, C Jin, Y-S Lee, S K Lee.   

Abstract

Since nitric oxide (NO) produced by inducible nitric oxide synthase (iNOS) has been found to be involved in various pathophysiological processes, including inflammation and carcinogenesis, the modulators of NO synthesis or expression have been considered as potential anti-inflammatory and cancer chemopreventive agents. In this study, to procure the iNOS inhibitors from natural products, we evaluated 57 methanol extracts of natural products including Korean indigenous plants for the inhibition of NO formation on lipopolysaccharide (LPS)-activated mouse macrophage-like RAW 264.7 cells. As a result, several extracts including those from Actinodaphne lancifolia, Calystegia soldanella, Caryratia japonica, Citrus dachibana, Dystaenia takeshimana, Erysimum aurantiacum, Hovenia undulata, Stewartia koreana and Viburnum awabuki showed potent inhibitory activities of NO production (>70% inhibition at the test concentration of 40 microg/ml). In particular, the extract of Calystegia soldanella showed a potential inhibition of NO production in a dose-dependent manner (IC50=4.3 microg/ml). Subsequent study also exhibited that the extract of Calystegia soldanella significantly suppressed iNOS protein and gene expression in a dose-dependent manner. These results suggest that Calystegia soldanella might be a new potential candidate for developing an iNOS inhibitor from natural products and also could be warranted for further elucidation of active principles for the development of new anti-inflammatory and/or cancer chemopreventive agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452455     DOI: 10.1097/00008469-200410000-00010

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  5 in total

1.  Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity.

Authors:  Tamara P Kondratyuk; Eun-Jung Park; Laura E Marler; Soyoun Ahn; Yang Yuan; Yongsoo Choi; Rui Yu; Richard B van Breemen; Bin Sun; Juma Hoshino; Mark Cushman; Katherine C Jermihov; Andrew D Mesecar; Clinton J Grubbs; John M Pezzuto
Journal:  Mol Nutr Food Res       Date:  2011-06-29       Impact factor: 5.914

2.  Cancer chemopreventive and anticancer evaluation of extracts and fractions from marine macro- and microorganisms collected from Twilight Zone waters around Guam.

Authors:  Peter J Schupp; Claudia Kohlert-Schupp; Susanna Whitefield; Anna Engemann; Sven Rohde; Thomas Hemscheidt; John M Pezzuto; Tamara P Kondratyuk; Eun-Jung Park; Laura Marler; Bahman Rostama; Anthony D Wright
Journal:  Nat Prod Commun       Date:  2009-12       Impact factor: 0.986

3.  Novel marine phenazines as potential cancer chemopreventive and anti-inflammatory agents.

Authors:  Tamara P Kondratyuk; Eun-Jung Park; Rui Yu; Richard B Van Breemen; Ratnakar N Asolkar; Brian T Murphy; William Fenical; John M Pezzuto
Journal:  Mar Drugs       Date:  2012-02-16       Impact factor: 6.085

4.  Crude extract and solvent fractions of Calystegia soldanella induce G1 and S phase arrest of the cell cycle in HepG2 cells.

Authors:  Jung Im Lee; In-Hye Kim; Taek-Jeong Nam
Journal:  Int J Oncol       Date:  2017-01-02       Impact factor: 5.650

5.  Dichloromethane fractions of Calystegia soldanella induce S‑phase arrest and apoptosis in HT‑29 human colorectal cancer cells.

Authors:  In-Hye Kim; Taekil Eom; Joon-Young Park; Hyung-Joo Kim; Taek-Jeong Nam
Journal:  Mol Med Rep       Date:  2021-12-22       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.